| Literature DB >> 35630313 |
Jingyan Fan1, Lelin Zhao1, Qiao Hu1, Siqi Li1, Haotian Li1, Qianqian Zhang1, Geng Zou1, Liangsheng Zhang1, Lu Li1,2,3, Qi Huang1,2,3, Rui Zhou1,2,3,4.
Abstract
Streptococcus suis (S. suis) is a zoonotic bacterial pathogen causing lethal infections in pigs and humans. Identification of virulence-related genes (VRGs) is of great importance in understanding the pathobiology of a bacterial pathogen. To identify novel VRGs, a transposon (Tn) mutant library of S. suis strain SC19 was constructed in this study. The insertion sites of approximately 1700 mutants were identified by Tn-seq, which involved 417 different genes. A total of 32 attenuated strains were identified from the library by using a Galleria mellonella larvae infection model, and 30 novel VRGs were discovered, including transcription regulators, transporters, hypothetical proteins, etc. An isogenic deletion mutant of hxtR gene (ΔhxtR) and its complementary strain (CΔhxtR) were constructed, and their virulence was compared with the wild-type strain in G. mellonella larvae and mice, which showed that disruption of hxtR significantly attenuated the virulence. Moreover, the ΔhxtR strain displayed a reduced survival ability in whole blood, increased sensitivity to phagocytosis, increased chain length, and growth defect. Taken together, this study performed a high throughput screening for VRGs of S. suis using a G. mellonella larvae model and further characterized a novel critical virulence factor.Entities:
Keywords: Galleria mellonella larvae; Streptococcus suis; hxtR; transposon mutant library; virulence-related genes
Year: 2022 PMID: 35630313 PMCID: PMC9143085 DOI: 10.3390/microorganisms10050868
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Bacterial strains, plasmids, and primers used in this study.
| Strains, Plasmids, or Primers | Relevant Characteristics and/or Sequences | Source or |
|---|---|---|
|
| ||
| Virulent serotype 2 strain | [ | |
| Δ | A | This work |
| CΔ | A complementary strain of SC19 | This work |
| F- | Vazyme | |
|
| ||
| pTV408 | For construction of | Dr. Tracy Wang |
| pSET4s | [ | |
| pSET4s-H | Derived from pSET4s used to knock out | This work |
| pSET2 | [ | |
| pSET2-CH | Derived from pSET2 for functional complementation of | This work |
|
| ||
| JPM48 | AATGCGGCCGCATGTCAGACATTTTAAA | This work |
| JPM49 | TTTATCTGGAACATCTGTGG | This work |
| JPM50 | AAGGGACCACCTATGATGTG | This work |
| JPM51 | CAGAAGGCAATGTCATACCA | This work |
|
| ||
| 16SrRNA-F | GTAGTCCACGCCGTAAACG | This work |
| 16SrRNA-R | TAAACCACATGCTCCACCGC | This work |
| GDH-F | GCAGCGTATTCTGTCAAACG | This work |
| GDH-R | CCATGGACAGATAAAGATGG | This work |
|
| ||
| 254 | CGACTGGACCTGGA | This work |
| 256 | GATAAGCAGGGATCGGAACCTCCAGGTCCAGTCG | This work |
| Tn917-seq | AGAGAGATGTCACCGTCAAGT | This work |
| 258 | GATAAGCAGGGATCGGAACC | This work |
|
| ||
| Δ | AATTCGAGCTCGGTACCCGGCATCTCCAGCATTTTCCTTC | This work |
| Δ | TAGGCTTAAAAATCATAAAATATCACCTAAAATCATGATTGTC | This work |
| Δ | TTAGGTGATATTTTATGATTTTTAAGCCTAGTTAATCACTAGT | This work |
| Δ | GCCTGCAGGTCGACTCTAGAGGGTTTCTGTAGAAGATTTTCCTA | This work |
| Δ | CATGCTGACAGGATAGACATAGGA | This work |
| Δ | AAGAGCAAGAATTTGGCATCG | This work |
| CΔ | AATTCGAGCTCGGTACCCGGTCGTAATCGGCTAATAAGTC | This work |
| CΔ | GCCTGCAGGTCGACTCTAGATCAATCTGGACTATAAATATCTACAA | This work |
| M13F | GTAAAACGACGGCCAGT | This work |
| M13R | CAGGAAACAGCTATGAC | This work |
| 5150-F | ATGAAAAGGATTACAGAGATTTCTTG | This work |
| 5150-R | TCATGTGAGAGGTTTTGACC | This work |
| ATGATTTTAGGTGATATTTTAAAAGAATACCG | This work | |
| TCAATCTGGACTATAAATATCTACAACTT | This work | |
| 5160-F | ATGTGGCCGGAGGAAAAGA | This work |
| 5160-R | TCAACTTTTTTGCTTTTCTTTTTCCTTGA | This work |
ErmR—erythromycin resistant; KanR—kanamycin resistant; AmpR—ampicillin resistant; SpcR—spectinomycin resistant.
Figure 1Location of transposon insertion sites in the genome of S. suis SC19. (A) Scatter plot of the positions of the Tn insertion sites. Blue spots represent the position (bp) of the 1665 mutants in the SC19 genome where the transposition inserted sites are located. (B) Mapping of the Tn insertion sites to the genome of S. suis SC19 strain. CGView Server was used to visualize the distribution of the inserted genes involved in the mutant library on the S. suis SC19 genome.
Figure 2The KEGG pathway enrichment of the 417 Tn917-inserted genes. The 417 genes were assigned with a K number by using the BlastKOALA tool. The K number was then used to map each gene to its corresponding KEGG pathway using the Reconstruct tool of the KEGG mapper. The enrichment ratio indicates the number of genes identified from the Tn mutant library in each KEGG pathway to the number of total genes included in the S. suis SC19 genome in this pathway.
Transposants with reduced virulence in Galleria mellonella larvae.
| Strain | Locus Tag | Product | Cumulative | Animal Modelref. |
|---|---|---|---|---|
| 4/6; 6/6; 6/6 | ||||
|
| ||||
| Tn1864 | B9H01_RS05155 | XRE family transcriptional regulator | 1/6; 2/6; 2/6 | |
| Tn491 | B9H01_RS04445 | DNA-binding response regulator | 1/6; 1/6; 6/6 | |
|
| ||||
| Tn722 | B9H01_RS07420 | Voltage-gated chloride channel protein | 2/6; 2/6; 3/6 | |
| Tn1673 | B9H01_RS04375 | MULTISPECIES: ABC transporter ATP-binding protein | 1/6; 3/6; 3/6 | |
| Tn1 | B9H01_RS00985 | Sugar ABC transporter permease | 0/6; 2/6; 4/6 | |
|
| ||||
| Tn1862 | B9H01_RS01125 | Formate C-acetyltransferase (PFL) | 0/6; 0/6; 0/6 | |
| Tn509 | B9H01_RS05230 | Peptidase | 1/6; 2/6; 2/6 | |
| Tn513 | B9H01_RS05380 | SAM-dependent methyltransferase | 0/6; 1/6; 2/6 | |
| Tn1712 | B9H01_RS07385 | Site-specific integrase | 1/6; 2/6; 2/6 | |
| Tn28 | B9H01_RS04890 | DUF1836 domain-containing protein | 1/6; 1/6; 3/6 | |
| Tn140 | B9H01_RS05665 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 2/6; 2/6; 3/6 | |
| Tn271 | B9H01_RS05640 | Beta-glucuronidase | 0/6; 1/6; 3/6 | |
| Tn660 | B9H01_RS05870 | Hyaluronidase | 0/6; 0/6; 0/6 | Not tested [ |
| Tn1803 | B9H01_RS05855 | Hyaluronidase | 1/6; 3/6; 4/6 | Not tested [ |
| Tn4 | B9H01_RS04330 | Phosphomannomutase/phosphoglucomutase | 0/6; 2/6; 4/6 | |
| Tn98 | B9H01_RS03990 | Subtilisin-like serine protease (SspA) | 1/6; 2/6; 4/6 | Mouse and pig [ |
| Tn220 | B9H01_RS03140 | Carbamate kinase (ArcC belongs to ADS) | 0/6; 2/6; 2/6 | Not tested [ |
| Tn376 | B9H01_RS10315 | Glycosyl hydrolase | 0/6; 1/6; 4/6 | |
| Tn454 | B9H01_RS05605 | Beta-hexosamidase | 0/6; 4/6; 4/6 | |
| Tn496 | B9H01_RS03375 | DUF975 domain-containing protein | 1/6; 3/6; 4/6 | |
| Tn866 | B9H01_RS04990 | 1,4-alpha-glucan branching protein (GlgB) | 1/6; 3/6; 4/6 | |
| Tn1823 | B9H01_RS05160 | A/G-specific adenine glycosylase | 1/6; 3/6; 4/6 | |
| Tn15 | B9H01_RS04765 | Glucan-binding protein | 0/6; 5/6; 5/6 | |
| Tn316 | B9H01_RS05135 | Integrase | 1/6; 2/6; 5/6 | |
| Tn656 | B9H01_RS06130 | Histidine triad protein | 1/6; 3/6; 5/6 | |
| Tn1761 | B9H01_RS00820 | Type II secretion pathway, pseudopilin (PulG) | 1/6; 3/6; 5/6 | |
|
| ||||
| Tn1624 | B9H01_RS03005 | Hypothetical protein | 0/6; 3/6; 4/6 | |
| Tn122 | B9H01_RS04405 | Hypothetical protein | 1/6; 2/6; 3/6 | |
| Tn12 | B9H01_RS00275 | Hypothetical protein | 1/6; 3/6; 4/6 | |
| Tn29 | B9H01_RS05145 | Hypothetical protein | 1/6; 3/6; 4/6 | |
| Tn524 | B9H01_RS04840 | Hypothetical protein | 1/6; 3/6; 4/6 | |
| Tn983 | B9H01_RS03005 | Hypothetical protein | 0/6; 4/6; 5/6 | |
Animal model indicates that the virulence of the gene was reported or the virulence was tested using animal infection models in S. suis.
Figure 3Virulence characterization of ΔhxtR, CΔhxtR, and SC19 strains. (A) G. mellonella larvae infection assay; 20 μL of bacterial cells (approximately 3 × 106 CFU) of ΔhxtR, CΔhxtR, and SC19 strains at the mid-log phase were used to inject larva from the left posterior proleg. Each group contained 10 larvae. The survival was recorded at 12 and 24 hpi and statistically analyzed using the log-rank (Mantel–Cox) test. * indicates p < 0.05, and *** indicates p < 0.001. (B) Mouse infection assay; 500 μL of bacterial cells (8.5 × 108 CFU) of ΔhxtR and SC19 strains at the mid-log phase were used to intraperitoneally inject mice. Each group contained 8 mice. The survival was recorded every 24 h post infection and statistically analyzed using the log-rank (Mantel–Cox) test. ** indicates p < 0.01. (C) Whole blood killing assay. Cells of ΔhxtR, CΔhxtR, and SC19 strains at the mid-log phase were mixed with freshly prepared anticoagulated mouse blood, followed by incubation at 37 °C for 30 min. The mixture was then plated on TSA plates for viable bacteria enumeration. The survival was calculated as (CFU recovered/CFU in original inoculum) × 100% and statistically analyzed using the Student’s t-test. ns indicates p > 0.05, * indicates p < 0.05, and ** indicates p < 0.01. (D) Macrophage phagocytosis assay. Cells of ΔhxtR, CΔhxtR, and SC19 strains were mixed with Raw264.7 macrophage cells with an MOI of 10:1, followed by incubation at 37 °C for 30 min. The cells were treated with ampicillin (50 μg/mL) to remove unphagocytized bacteria. The cells were then lysed, and the phagocytized bacteria were isolated and enumerated by plating on TSA plates. Statistical significances were determined by using the Student’s t-test. ns indicates p > 0.05, and ** indicates p < 0.01.
Figure 4Cell morphology and growth characterizations of ΔhxtR, CΔhxtR, and SC19 strains. (A) Morphological analysis by Gram staining. The cells of each indicated strain were grown to the mid-log phase, washed, subjected to regular Gram staining, and imaged under a light microscope. The scale bar is 10 μm. (B) Morphological analysis with SIM. The cells of each indicated strain were grown to the mid-log phase, washed, stained with fluorescent dye Alexa Fluor 647, and imaged using a two-color structure illumination microscope (SIM; Nikon Instruments, Tokyo, Japan) with excitation at 651 nm and emission at 672 nm. (C) Comparison of bacterial chain length. Over one hundred chains per sample were randomly selected in different fields from the Gram staining images to measure the length of the chain by using the software Image-Pro, and then the average chain length was calculated (in µm) and statistically analyzed using the Student’s t-test. **** indicates p < 0.0001. (D) Growth assay. The overnight cultures of the strains were diluted to an initial OD600 of 0.01 with TSB, and then, the diluted culture was pipetted into a microplate. The plate was incubated at 37 °C with continuous shaking for 14 h, and the optical density at 600 nm was monitored every 1 h.